Although CDH1 also plays an important role in pluripotent stem cell self-renewal and may therefore be downregulated during the differentiation process, this protein poses a potential cancer-related risk if expressed in the final therapeutic cell population because its expression indicates the presence of stem cells capable of producing benign but proliferating tumours. The gene discussed is CDH1; the disease is cancer.